ImmuCell Corporation (ICCC): Company Short-Term Debts
ImmuCell Corporation (ICCC) is protected by patents for First Defense biologicals and strict USDA oversight. The company is implementing eco-friendly agrotechnologies, replacing antibiotics in livestock farming. Changes in short-term liabilities demonstrate the dynamics of current debt, where the current value equals 0.00. Diversified raw material procurement and streamlined vaccine distribution logistics to US farms ensure the stability of the forecast.
ImmuCell Corporation Inc (ICCC) - metric breakdowns and financial figures
To minimize credit risks, an investor must evaluate the aggregate of liabilities maturing within twelve months, which reflects the issuer's current solvency. Analyzing changes in short-term liabilities reveals how effectively ImmuCell Corporation (ICCC) manages borrowed capital to maintain its monopoly position in the oral immunoglobulin segment for calf protection within the global veterinary market.